Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
Carlsquare Equity Research comments on a recently published article and report concerning increasing incidence rates of Candidozyma auris (formerly known as Candida auris).
Read the full comment here.